Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (7)

2023

  1. ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

    Nature Communications, Vol. 14, Núm. 1

2019

  1. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas

    Head and Neck, Vol. 41, Núm. 1, pp. 79-91

  2. Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations

    The Journal of clinical endocrinology and metabolism, Vol. 104, Núm. 11, pp. 5673-5692

2017

  1. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate

    Oncotarget, Vol. 8, Núm. 4, pp. 6700-6717

2015

  1. Bone microenvironment signals in osteosarcoma development

    Cellular and Molecular Life Sciences, Vol. 72, Núm. 16, pp. 3097-3113

2012

  1. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma

    Clinical Cancer Research, Vol. 18, Núm. 10, pp. 2828-2837

2004

  1. Efficacy of piperacillin-tazobactam in the treatment of surgical wound infection after clean-contaminated head and neck oncologic surgery

    Head and Neck, Vol. 26, Núm. 9, pp. 823-828